Showing 1041-1050 of 4671 results for "".
Robert Grant Steps Down at Alphaeon; Skin Cancer Special Edition
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-robert-grant-steps-down-at-alphaeon-skin-cancer-special-edition/18595/Robert Grant is no longer CEO of lifestyle healthcare company Alphaeon. Mr. Grant founded Alphaeon in 2013 as a wholly owned subsidiary of Strathspey Crown LLC, a private equity firm located in Newport Beach, CA, where he serves as Chairman. Also in this issue, a closer look at skin cancer. May is SDupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects sWarfarin-Induced Nonuremic Calciphylaxis: A Case Study and Overview
https://practicaldermatology.com/youngmd-connect/resident-resource-center/warfarin-induced-nonuremic-calciphylaxis-a-case-study-and-overview/23872/Pro Tip: Addressing Marginal Mandibular Nerve Paresis Following Submental Deoxycholate Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pro-tip-addressing-marginal-mandibular-nerve-paresis-following-submental-deoxycholate-injections/23734/An expert shares a simple fix to a potential unintended treatment outcome.Developing Core Outcome Sets: The Importance of Common Standards for Clinical Studies of Specific Diseases and Conditions
https://practicaldermatology.com/topics/feature/developing-core-outcome-sets-importance-common-standards-clinical-studies-specific-diseases-and-conditions/26654/Developing Core Outcome Sets: The Importance of Common Standards for Clinical Studies of Specific Diseases and ConditionsCSF After Dark
https://practicaldermatology.com/topics/practice-management/csf-after-dark/20404/What happens in Vegas stays in Vegas. Or does it?New Products/New In My Practice: Rx
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-rx/23039/Staphylococcus aureus and Atopic Dermatitis: Unweaving a Tangled Web
https://practicaldermatology.com/topics/general-topics/staphylococcus-aureus-and-atopic-dermatitis-unweaving-a-tangled-web/22083/Though the relationship is not fully understood, it points the way to potential treatments.The Inside Scoop on Cosmeceuticals: From Top to Bottom
https://practicaldermatology.com/topics/general-topics/the-inside-scoop-on-cosmeceuticals-from-top-to-bottom/20896/Top derms dish about their favorite cosmeceuticals, including options beyond wrinkle fighting.BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to Dian